Proteotype Unveils Alchemi®, Data and Orchestration Platform for Enlighten®
Proteotype Diagnostics, based in Portugal, unveiled Alchemi, a proprietary data and clinical workflow platform. This platform is designed to support the company's investigational blood-based multi-cancer test, Enlighten, aiming to securely connect lab measurements and multi-country clinical data while enhancing interoperability across healthcare settings.